DE NOVO

Clinical trials for DE NOVO explained in plain language.

Never miss a new study

Get alerted when new DE NOVO trials appear

Sign up with your email to follow new studies for DE NOVO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New Triple-Drug attack shows promise for older AML patients

Disease control Completed

This study tested a combination of three drugs (low-dose cytarabine or azacitidine, plus venetoclax and quizartinib) in 113 adults aged 60 and older with newly diagnosed acute myeloid leukemia (AML) who could not receive standard chemotherapy. The goal was to quickly control the …

Matched conditions: DE NOVO

Phase: PHASE1, PHASE2 • Sponsor: PETHEMA Foundation • Aim: Disease control

Last updated May 22, 2026 13:50 UTC

DE NOVO

Get alerted when new DE NOVO trials appear

New Triple-Drug attack shows promise for older AML patients